Distinct Trypanosoma cruzi genotypes have been considered relevant for patient management and therapeutic response of Chagas disease. However, typing strategies for genotype-specific serodiagnosis of Chagas disease are still unavailable and requires standardization for practical application. In this study, an innovative TcI/TcVI/TcII Chagas Flow ATE-IgG2a technique was developed with applicability for universal and genotype-specific diagnosis of T. cruzi infection. For this purpose, the reactivity of serum samples (percentage of positive fluorescent parasites-PPFP) obtained from mice chronically infected with TcI/Colombiana, TcVI/CL or TcII/Y strain as well as non-infected controls were determined using amastigote-AMA, trypomastigote-TRYPO and epimastigote-EPI in parallel batches of TcI, TcVI and TcII target antigens. Data demonstrated that "α-TcII-TRYPO/1:500, cut-off/PPFP = 20%" presented an excellent performance for universal diagnosis of T. cruzi infection (AUC = 1.0, Se and Sp = 100%). The combined set of attributes "α-TcI-TRYPO/1:4,000, cut-off/PPFP = 50%", "α-TcII-AMA/1:1,000, cut-off/PPFP = 40%" and "α-TcVI-EPI/1:1,000, cut-off/PPFP = 45%" showed good performance to segregate infections with TcI/Colombiana, TcVI/CL or TcII/Y strain. Overall, hosts infected with TcI/Colombiana and TcII/Y strains displayed opposite patterns of reactivity with "α-TcI TRYPO" and "α-TcII AMA". Hosts infected with TcVI/CL strain showed a typical interweaved distribution pattern. The method presented a good performance for genotype-specific diagnosis, with global accuracy of 69% when the population/prototype scenario include TcI, TcVI and TcII infections and 94% when comprise only TcI and TcII infections. This study also proposes a receiver operating reactivity panel, providing a feasible tool to classify serum samples from hosts infected with distinct T. cruzi genotypes, supporting the potential of this method for universal and genotype-specific diagnosis of T. cruzi infection.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380352 | PMC |
| http://dx.doi.org/10.1371/journal.pntd.0005444 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
In vitro assays identified thiohydantoins with anti-trypanosomatid activity and molecular modelling studies indicated possible selective CYP51 inhibition.
Sci Rep
January 2025
Departamento de Química, Centro de Ciências Exatas, Universidade Estadual de Londrina, Londrina, PR, Brasil.
This work investigates the anti-trypanosomal activities of ten thiohydantoin derivatives against the parasite Trypanosoma cruzi. Compounds with aliphatic chains (THD1, THD3, and THD5) exhibited the most promising IC against the epimastigote form of T. cruzi.
View Article and Find Full Text PDFSynthesis strategies and anti-parasitic evaluation of novel compounds for chagas disease: Advancing drug discovery through structure-activity relationships.
Eur J Med Chem
December 2024
School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, India. Electronic address:
This study presents a comprehensive exploration of the synthesis of novel compounds targeting Chagas Disease (CD) caused by Trypanosoma cruzi. It is a global health threat with over 6-7 million infections worldwide. Addressing challenges in current treatments, the investigation explores diverse compound classes, including thiazoles, thiazolidinone, imidazole, pyrazole, 1,6-diphenyl-1H-pyrazolo[3,4-b] pyridine, pyrrole, naphthoquinone, neolignan, benzeneacyl hydrazones, and chalcones-based compounds.
View Article and Find Full Text PDFMorphological and molecular characterization of a Sarcocystis bovifelis-like sarcocyst in American beef.
Parasit Vectors
December 2024
United States Department of Agriculture, Agricultural Research Service, Beltsville Agricultural Research Centre, Animal Parasitic Diseases Laboratory, Beltsville, MD, 20705-2350, USA.
Background: Parasites in the apicomplexan genus Sarcocystis infect cattle worldwide. Assessing the economic importance of each such parasite species requires proper diagnosis. Sarcocystis cruzi, a thin-walled species, infects virtually all cattle.
View Article and Find Full Text PDFHigh infection prevalences by Trypanosoma minasense in non-human primates from the Southeast region of Brazil.
Sci Rep
December 2024
Laboratório de Biologia de Tripanosomatídeos, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Article Synopsis
- Non-human primates (NHPs) in Brazil were studied to investigate the infection rates of Trypanosoma minasense, with a focus on how landscape composition and forest fragmentation affected these rates.
- Sapajus nigritus showed the highest positivity for T. minasense in blood samples (60.9%), while other species like Callithrix spp. and Alouatta guariba clamitans had lower rates, but molecular analysis indicated significant infections in all groups.
- The study found a correlation between T. minasense infections and environmental factors: higher forest fragmentation led to increased infection rates in NHPs, suggesting that habitat loss may drive disease prevalence.
First Report of Rhodnius stali Lent, Jurberg, and Galvão 1993 (Hemiptera: Reduviidae: Triatominae) Naturally Infected by Trypanosoma cruzi in Concepción Department, Paraguay.
Am J Trop Med Hyg
December 2024
Centro para el Desarrollo de la Investigación Científica, Asunción, Paraguay.
Article Synopsis
- Most triatomine bugs are found in the nests of vertebrates, often near palm trees, with some species living in human habitats and capable of spreading Chagas disease.
- A specimen identified as Rhodnius stali was discovered in northeastern Paraguay and tested positive for Trypanosoma cruzi, marking a new first for the species in the country.
- This finding highlights the need for enhanced surveillance and vector control measures to address the potential spread of Chagas disease in Paraguay.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!